Lung Cancer

Cigarette smoking-attributable cancer deaths appeared associated with nearly 2.2 million person-years of life lost and $20.9 billion in lost earnings across the United States in 2019, according to study results.

Data show that late-stage cancer diagnoses are rising in the United States due to the drop in screenings during the COVID-19 pandemic.

Irinotecan liposomal injection as second-line treatment of small cell lung cancer failed to extend OS compared with topotecan, according to the agent’s manufacturer.

Residents of low area-level income and education areas had higher odds of having late-stage non-small cell lung cancer at diagnosis than residents of high area-level income and education areas, according to study results.

World Lung Cancer Day will be held Aug. 1.

Mental health plays a significant role in overall health, and addressing these concerns is no less important in patients with lung cancer, according to experts.

Community-dwelling older adult smokers for whom annual low-dose CT screening is not recommended had a 10-fold higher risk for lung cancer compared with never smokers, according to study results.

During the early months of the COVID-19 pandemic, the number of cancer screenings in the U.S. dropped sharply as states imposed stay-at-home orders and health care providers sought to reduce exposure to the virus and redeployed personnel.

Within the past decade, data have emerged indicating an effective role of circulating tumor DNA in identifying lung cancer at an early stage and in matching patients with appropriate treatments.

In this video, Ravi Salgia, MD, PhD, discussed findings from two studies presented at ASCO Annual Meeting — one investigating immunotherapy and the other targeted therapy — for the treatment of lung cancer.